Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riess

Showing results (1141-1150 of 1,489) with videos related to

Pageof 149
Sort By:
Atherosclerosis|February 22, 2023
KLKB1 and CLSTN2 are associated with HDL-mediated cholesterol efflux capacity in a genome-wide association studyJohanna F Schachtl-Riess, Sebastian Schönherr, Claudia Lamina, et al.
Frontiers in Behavioral Neuroscience|November 12, 2016
Impaired Decision Making and Loss of Inhibitory-Control in a Rat Model of Huntington DiseaseNicole El Massioui, Charlotte Lamirault, Sara Yagüe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2017
Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective DatabaseSukhmani K Padda, Xiaopan Yao, Alberto Antonicelli, et al.
Lung Cancer (Amsterdam, Netherlands)|May 5, 2012
ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapyMillie Das, Jonathan W Riess, Paul Frankel, et al.
JTO Clinical and Research Reports|November 19, 2025
DLL3 Immunohistochemical Expression in Neuroendocrine-Transformed <i>EGFR</i>-Mutant Lung Cancer and Two Cases of Tarlatamab TherapyJacqueline V Aredo, Surbhi Singhal, Gerald J Berry, et al.
Neuroimage. Clinical|May 21, 2023
Parkinson's disease may disrupt overlapping subthalamic nucleus and pallidal motor networksAlejandro N Santos, Ferath Kherif, Lester Melie-Garcia, et al.
Frontiers in Neuroscience|February 10, 2018
Early Alterations in Operant Performance and Prominent Huntingtin Aggregation in a Congenic F344 Rat Line of the Classical CAG<sub>n51trunc</sub> Model of Huntington DiseaseAnne-Christine Plank, Fabio Canneva, Kerstin A Raber, et al.
Frontiers in Oncology|August 13, 2021
Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 StudyJana Käthe Striefler, Hanno Riess, Philipp Lohneis, et al.
Human Molecular Genetics|May 27, 2008
Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in malesFelix J Bode, Michael Stephan, Hendrik Suhling, et al.
Human Molecular Genetics|January 15, 2008
Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's diseaseSilke Metzger, Juan Rong, Huu-Phuc Nguyen, et al.
Pageof 149

Showing results (1141-1150 of 1,489) with videos related to

Sort By:
Pageof 149
Atherosclerosis|February 22, 2023
KLKB1 and CLSTN2 are associated with HDL-mediated cholesterol efflux capacity in a genome-wide association studyJohanna F Schachtl-Riess, Sebastian Schönherr, Claudia Lamina, et al.
Frontiers in Behavioral Neuroscience|November 12, 2016
Impaired Decision Making and Loss of Inhibitory-Control in a Rat Model of Huntington DiseaseNicole El Massioui, Charlotte Lamirault, Sara Yagüe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2017
Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective DatabaseSukhmani K Padda, Xiaopan Yao, Alberto Antonicelli, et al.
Lung Cancer (Amsterdam, Netherlands)|May 5, 2012
ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapyMillie Das, Jonathan W Riess, Paul Frankel, et al.
JTO Clinical and Research Reports|November 19, 2025
DLL3 Immunohistochemical Expression in Neuroendocrine-Transformed <i>EGFR</i>-Mutant Lung Cancer and Two Cases of Tarlatamab TherapyJacqueline V Aredo, Surbhi Singhal, Gerald J Berry, et al.
Neuroimage. Clinical|May 21, 2023
Parkinson's disease may disrupt overlapping subthalamic nucleus and pallidal motor networksAlejandro N Santos, Ferath Kherif, Lester Melie-Garcia, et al.
Frontiers in Neuroscience|February 10, 2018
Early Alterations in Operant Performance and Prominent Huntingtin Aggregation in a Congenic F344 Rat Line of the Classical CAG<sub>n51trunc</sub> Model of Huntington DiseaseAnne-Christine Plank, Fabio Canneva, Kerstin A Raber, et al.
Frontiers in Oncology|August 13, 2021
Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 StudyJana Käthe Striefler, Hanno Riess, Philipp Lohneis, et al.
Human Molecular Genetics|May 27, 2008
Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in malesFelix J Bode, Michael Stephan, Hendrik Suhling, et al.
Human Molecular Genetics|January 15, 2008
Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's diseaseSilke Metzger, Juan Rong, Huu-Phuc Nguyen, et al.
Pageof 149